Literature DB >> 33552774

Adrenal Pheochromocytoma Treated With Stereotactic Body Radiation Therapy.

Iván D González1, Alexandra Vallejo1, Eduardo Guerrero Lizcano2, Alexandra Pabón Girón3.   

Abstract

Pheochromocytoma is a rare neuroendocrine tumor arising from chromaffin cells in the adrenal medulla. In most cases, it is benign and tends to remain localized. However since it leads to the development of cardiovascular disease, it is associated with high rates of morbidity and mortality. Treatment options include medical, surgical, or ablative measures, which often adequately control the disease. Primary pheochromocytoma is conventionally treated with external beam radiation therapy (EBRT), while stereotactic body radiation therapy (SBRT) is preferred for cases with metastasis. However, literature regarding the use of SBRT for the treatment of primary disease is scarce. This case report describes a patient with an inoperable primary adrenal gland pheochromocytoma who was treated with SBRT, resulting in adequate symptomatic control during clinical follow-up.
Copyright © 2021, González et al.

Entities:  

Keywords:  metanephrines; pheochromocytoma; sbrt; symptomatic control

Year:  2021        PMID: 33552774      PMCID: PMC7856918          DOI: 10.7759/cureus.12456

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

Review 1.  SBRT: A viable option for treating adrenal gland metastases.

Authors:  Edy Ippolito; Rolando Maria D'Angelillo; Michele Fiore; Elisabetta Molfese; Lucio Trodella; Sara Ramella
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-19

2.  Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy.

Authors:  Jeremy F McBride; Thomas D Atwell; William J Charboneau; William F Young; Thomas C Wass; Matthew R Callstrom
Journal:  J Vasc Interv Radiol       Date:  2011-09       Impact factor: 3.464

3.  Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer.

Authors:  Richard Holy; Marc Piroth; Michael Pinkawa; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2011-03-21       Impact factor: 3.621

4.  Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.

Authors:  Tuan H Pham; Christopher Moir; Geoffrey B Thompson; Abdalla E Zarroug; Chad E Hamner; David Farley; Jon van Heerden; Aida N Lteif; William F Young
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

Review 5.  von Hippel-Lindau disease: a clinical and scientific review.

Authors:  Eamonn R Maher; Hartmut Ph Neumann; Stéphane Richard
Journal:  Eur J Hum Genet       Date:  2011-03-09       Impact factor: 4.246

Review 6.  Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging.

Authors:  Katherine Leung; Michael Stamm; Asim Raja; Gavin Low
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

7.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

8.  Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

Authors:  E R Maher; A R Webster; F M Richards; J S Green; P A Crossey; S J Payne; A T Moore
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

9.  External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma.

Authors:  Jennifer Vogel; Aileen Sia Atanacio; Tamara Prodanov; Baris Ismail Turkbey; Karen Adams; Victoria Martucci; Kevin Camphausen; Antonio Tito Fojo; Karel Pacak; Aradhana Kaushal
Journal:  Front Oncol       Date:  2014-06-27       Impact factor: 6.244

10.  External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma.

Authors:  William Breen; Irina Bancos; William F Young; Keith C Bible; Nadia N Laack; Robert L Foote; Christopher L Hallemeier
Journal:  Adv Radiat Oncol       Date:  2017-11-22
View more
  1 in total

Review 1.  Management of Pheochromocytomas and Paragangliomas: A Case-Based Review of Clinical Aspects and Perspectives.

Authors:  Bartosz Kamil Sobocki; Adrian Perdyan; Olga Szot; Jacek Rutkowski
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.